Trial intelligence / Profile preview

Triple vs Dual Antiplatelet Therapy with Cilostazol in ACS

NCT00404716Phase 4Completed

Sponsor
General Hospital of the Northern Theater Command
Start
Dec 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of cilostazol in acute coronary syndrome (ACS), sponsored by General Hospital of the Northern Theater Command. Started Dec 2004; status: completed.

02

Drugs

cilostazol
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT00404716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00404716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call